Hi,

Dr. Elke Reissig from BayerSchering AG will provide a presentation on the 1st World Congress on Controversies in Neurology to be held 6-9 September in Berlin.
http://www.comtecmed.com/cony/

Title of the presentation: Spheramine cell therapy.
As all patients of the phase IIb study in the meantime got the surgery maybe we will get some preliminary results whether the positive results from the phase I study will be confirmed and as a result this approach can provide a promising alterantive for all people suffering advanced PD.

Information regarding the risks and the safety profile would also be helpful.

frank